Jianqing Xu

36PUBLICATIONS
95CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsInnate immunityAnimal protection (incl. pests and pathogens)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 31, 2026
KREMEN1 residue W94 is essential for receptor binding and infection by a major group of enteroviruses.

|Feb 10, 2026
Harnessing tumor acidity: innovative lactic acid-responsive promoter enables precision control of CAR-T cell activity in solid tumors.

Meiqi Feng, Linxia Zhang, Qibin Liao

|Nov 24, 2025
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures.

Aira F Cabug, Jeremy Chase Crawford, Hayley A McQuilten

|Oct 03, 2025
Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations.

Zhendong Pan, Liangliang Jiang, Yingying Chen

|Sep 05, 2025
COG6 is an essential host factor for influenza A virus infection.

Daobin Feng, Jiaohan Guo, Jingjing Yan

|Apr 18, 2025
Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice.

Shimeng Bai, Xinghao Pan, Tianhan Yang

Pageof 6

Frequent Collaborators

12 joint publications

Xiaoyan Zhang

5 joint publications

Chen Zhao

3 joint publications

Jeremy Chase Crawford

3 joint publications

Wei Zhang